Home β€Ί Stock analysis β€Ί CUVL

Clinuvel Pharmaceuticals (CUVL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

CUVL jumps 3.5% to $5.24. Closed at $5.24, +3.46% vs the prior close of $5.06. Day range $5.18–$5.38, opened at $5.38.

Last close$5.24+3.46%
Day range5.18–5.38
Open5.38
Volume3.33K
52-week range4.91–8.92
Avg volume (20d)7.99K

CUVL daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” CUVL jumps 3.5% to $5.24
Oct 15, 2026 β€” CUVL slides 4.5% to $5.06, a 52-week low, 6 down days in a row
Oct 14, 2026 β€” CUVL dips 2.6% to $5.30, a 52-week low, 5 down days in a row
Oct 13, 2026 β€” CUVL dips 2.5% to $5.44, a 52-week low, 4 down days in a row
Oct 12, 2026 β€” CUVL ends flat (-0.2%) to $5.58, a 52-week low, 3 down days in a row
Oct 9, 2026 β€” CUVL ends flat (-0.2%) to $5.59, a 52-week low
Oct 8, 2026 β€” CUVL slides 3.4% to $5.60, a 52-week low
Oct 7, 2026 β€” CUVL rises 2.3% to $5.80
Oct 6, 2026 β€” CUVL dips 1.2% to $5.67
Oct 5, 2026 β€” CUVL slides 4.8% to $5.74
Oct 2, 2026 β€” CUVL jumps 6.5% to $6.03

CUVL latest news & SEC filings

Every SEC filing by or about CUVL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-047083

Oct 7, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-046056

Oct 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-045459

Oct 1, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-045210

Sep 9, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-041832

Aug 27, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-040352

Aug 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-039339

Aug 12, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-037231

Jul 30, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-035316

Jul 28, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-034917

Jul 27, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-034760

Jul 23, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-034387

Jul 22, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-034137

Jul 22, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-034136

Jul 17, 2026 Β· Form SEC STAFF ACTION β€” SEC STAFF ACTION filing

SEC STAFF ACTION filing

Source: SEC EDGAR filing 9999999997-26-001235

Things to know before you trade CUVL

CUVL market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20265.385.385.185.243.33K
Oct 15, 20264.915.234.915.063.40K
Oct 14, 20265.385.395.305.303.60K
Oct 13, 20265.605.605.425.445.00K
Oct 12, 20265.705.805.585.5810.50K
Oct 9, 20265.565.595.565.591.60K
Oct 8, 20265.655.655.535.6013.80K
Oct 7, 20265.755.805.725.802.20K
Oct 6, 20265.655.745.655.673.50K
Oct 5, 20265.725.745.655.749.60K
Oct 2, 20266.036.036.036.031.00K
Oct 1, 20265.575.745.575.6610.40K
Sep 30, 20265.916.005.905.9613.10K
Sep 29, 20265.765.875.765.872.20K
Sep 28, 20265.665.805.635.758.70K
Sep 25, 20265.825.825.605.6313.30K
Sep 24, 20265.885.885.785.782.40K
Sep 23, 20265.875.875.765.798.30K
Sep 22, 20265.805.905.795.804.60K
Sep 21, 20265.855.905.705.8039.30K

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals (CUVL) is listed on the Nasdaq and classified by the SEC under β€œAmerican Depositary Receipts”. Its business address is in MELBOURNE, VICTORIA. State of incorporation: Australia. Fiscal year ends June 30. SEC CIK 1290877.

CUVL board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

CUVL financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

CUVL earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on CUVL

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.